Lung cancer incidence trends by gender, race and histology in the United States, 1973-2010

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Meza, Rafael ^a   Meernik, Clare ^a   Jeon, Jihyoun ^b   Cote, Michele L ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; AGE; ARTICLE; BLACK PERSON; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER REGISTRY; CAUCASIAN; COMORBIDITY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; MALE; RACE DIFFERENCE; SEX DIFFERENCE; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; TREND STUDY; UNITED STATES; ADENOCARCINOMA; ANCESTRY GROUP; CARCINOMA, LARGE CELL; CARCINOMA, SQUAMOUS CELL; HISTORY; INCIDENCE; LUNG NEOPLASMS; SMALL CELL LUNG CARCINOMA; TRENDS;

NICOTIANA TABACUM;

ADENOCARCINOMA; CARCINOMA, LARGE CELL; CARCINOMA, SQUAMOUS CELL; CONTINENTAL POPULATION GROUPS; FEMALE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; SEER PROGRAM; SEX FACTORS; SMALL CELL LUNG CARCINOMA; UNITED STATES;

EID: 84926432208     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121323     Document Type: Article

References (43)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013; 63(1): 11-30. doi: 10.3322/caac.21166 PMID: 23335087
2. Travis WD, Lubin J, Ries L, Devesa S. United States lung carcinoma incidence trends: Declining for most histologic types among males, increasing among females. Cancer. 1996; 77(12): 2464-70. PMID: 8640694
3. Centers for Disease Control and Prevention (CDC). Smoking-attributable mortality, years of potential life lost, and productivity losses - United States, 2000-2004. MMWR Morb Mortal Wkly Rep. 2008; 57 (45): 1226-8. PMID: 19008791
4. Kenfield SA, Wei EK, Stampfer MJ, Rosner BA, Colditz GA. Comparison of aspects of smoking among the four histological types of lung cancer. Tob Control. 2008; 17(3): 198-204. doi: 10.1136/tc.2007.022582 PMID: 18390646
5. Haiman CA, Stram DO, Wilkens LR, Pike MC, Kolonel LN, Henderson BE, et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med. 2006; 354(4): 333-42. PMID: 16436765
6. Yun YH, Lim MK, Jung KW, Bae JM, Park SM, Shin SA, et al. Relative and absolute risks of cigarette smoking on major histologic types of lung cancer in Korean men. Cancer Epidemiol Biomarkers Prev. 2005; 14(9): 2125-30. PMID: 16172220
7. Morabia A, Wynder EL. Cigarette smoking and lung cancer cell types. Cancer. 1991; 68(9): 2074-8. PMID: 1655236
8. Yoshimi I, Ohshima A, Ajiki W, Tsukuma H, Sobue T. A comparison of trends in the incidence rate of lung cancer by histological type in the Osaka cancer registry, Japan and in the surveillance, epidemiology and end results program, USA. Jpn J Clin Oncol. 2003; 33(2): 98-104. PMID: 12629062
9. Khuder SA, Mutgi AB. Effect of smoking cessation on major histologic types of lung cancer. Chest. 2001; 120(5): 1577-83. PMID: 11713137
10. U.S. Department of Health and Human Services. Public Health Service. Office of the Surgeon General. Chapter 6. Cancer. In: U.S. Department of Health and Human Services. The Health Consequences of Smoking - 50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014. pp. 139-351.
11. Burns DM, Anderson CM, Gray N. Do changes in cigarette design influence the rise in adenocarcinoma of the lung? Cancer Causes Control. 2011; 22(1): 13-22. doi: 10.1007/s10552-010-9660-0 PMID: 20967496
12. Burns DM, Anderson CM, Gray N. Has the lung cancer risk from smoking increased over the last fifty years? Cancer Causes Control. 2011; 22(3): 389-97. doi: 10.1007/s10552-010-9708-1 PMID: 21188493
13. Holford TR, Levy DT, McKay LA, Clarke L, Racine B, Meza R. Patterns of birth cohort-specific smoking histories, 1965-2009. Am J Prev Med. 2014; 46(2): e31-e37. doi: 10.1016/j.amepre.2013.10.022 PMID: 24439359
14. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365(5): 395-409. doi: 10.1056/NEJMoa1102873 PMID: 21714641
15. Moyer VA. Screening for lung cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2013; 160(5): 330-8.
16. de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J. Benefits and harms of computed tomography lung cancer screening strategies: A comparative modeling study for the U.S. preventive services task force. Ann Intern Med. 2014; 160(5): 311-20. doi: 10.7326/M13-2316 PMID: 24379002
17. Ma J, Ward EM, Smith R, Jemal A. Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer. 2013; 119(7): 1381-5. doi: 10.1002/cncr.27813 PMID: 23440730
18. Patz EF Jr, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemagi MC. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med. 2013; 174(2): 269-274.
19. Devesa SS, Bray F, Vizcaino AP, Parkin DM. International lung cancer trends by histologic type: Male: Female differences diminishing and adenocarcinoma rates rising. Int J Cancer. 2005; 117(2): 294-9. PMID: 15900604
20. Govindan R, Page N, Morgensztern D, Read W, Tierney R, Vlahiotis A. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol. 2006; 24(28): 4539-44. PMID: 17008692
21. Janssen-Heijnen ML, Coebergh JW. Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe. Lung Cancer. 2001; 31(2-3): 123-37.
22. Li X, Mutanen P, Hemminki K. Gender-specific incidence trends in lung cancer by histological type in Sweden, 1958-1996. Eur J Cancer Prev. 2001; 10(3): 227-35. PMID: 11432709
23. Makitaro R, Paakko P, Huhti E, Bloigu R, Kinnula VL. An epidemiological study of lung cancer: History and histological types in a general population in northern Finland. Eur Respir J. 1999; 13(2): 436-40. PMID: 10065694
24. Thun MJ, Lally CA, Flannery JT, Calle EE, Flanders WD, Heath CW Jr. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst. 1997; 89(21): 1580-6. PMID: 9362155
25. Tse LA, Mang OW, Yu IT, Wu F, Au JS, Law SC. Cigarette smoking and changing trends of lung cancer incidence by histological subtype among Chinese male population. Lung Cancer. 2009; 66(1): 22-7. doi: 10.1016/j.lungcan.2008.12.023 PMID: 19185950
26. Lewis DR, Check DP, Caporaso NE, Travis WD, Devesa SS. US lung cancer trends by histologic type. Cancer. 2014; 120(18): 2883-92. doi: 10.1002/cncr.28749 PMID: 25113306
27. Surveillance, epidemiology, and end results (SEER) program. SEER∗Stat database: Incidence - SEER 9 regs research data, nov 2011 sub, vintage 2009 pops (1973-2009) 〈Katrina/Rita population adjustment〉 - linked to county attributes - total U.S., 1969-2010 counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2012, based on the November 2011 submission.
28. Egevad L, Heanue M, Berney D, Fleming K, Ferlay J. Chapter 4: Histological groups. In: Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al., editors. Cancer incidence in five continents. Volume IX. Lyon, France: IARC Scientific Publications No. 160; 2008.
29. SEER∗Stat software. Version 8.1.2. Surveillance Research Program, National Cancer Institute. Accessed: seer.cancer.gov/seerstat.
30. Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res. 2006; 15(6): 547-69. PMID: 17260923
31. Joinpoint regression program. Version 4.0.4. Surveillance Research Program, National Cancer Institute. Accessed: surveillance.cancer.gov/joinpoint/.
32. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19(3): 335-51. PMID: 10649300
33. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. Wolters Kluwer Health; 2008.
34. Conde E, Angulo B, Izquierdo E, Paz-Ares L, Belda-Iniesta C, Hidalgo M, et al. Lung adenocarcinoma in the era of targeted therapies: Histological classification, sample prioritization, and predictive biomarkers. Clin Transl Oncol. 2013; 15(7): 503-8. doi: 10.1007/s12094-012-0983-z PMID: 23359174
35. Langer CJ, Besse B, Gualberto A, Brambilla E, Soria JC. The evolving role of histology in the management of advanced non-small-cell lung cancer. J Clin Oncol. 2010; 28(36): 5311-20. doi: 10.1200/JCO.2010.28.8126 PMID: 21079145
36. Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, Kohler B, et al. Annual report to the nation on the status of cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013; 105(3): 175-201. doi: 10.1093/jnci/djs491 PMID: 23297039
37. Cancer facts & figures for African Americans. Atlanta, Georgia: American Cancer Society; 2014.
38. McCarthy WJ, Meza R, Jeon J, Moolgavkar SH. Lung cancer in never smokers. Epidemiology and risk prediction models. Risk Anal. 2012; 32(Suppl 1): S69-84. doi: 10.1111/j.1539-6924.2012.01768.x PMID: 22882894
39. Pesch B, Kendizia B, Gustavsson P, Jockel KH, Johnen G, Pohlabeln H, et al. Cigarette smoking and lung cancer - relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer. 2012; 131(5): 1210-9. doi: 10.1002/ijc.27339 PMID: 22052329
40. Pinsky PF, Church TR, Izmirlian G, Kramer BS. The national lung screening trial: Results stratified by demographics, smoking history, and lung cancer histology. Cancer. 2013; 119(22): 3976-83. doi: 10.1002/cncr.28326 PMID: 24037918
41. Etzel CJ, Kachroo S, Liu M, D'Amelio A, Dong Q, Cote ML, et al. Development and validation of a lung cancer risk prediction model for African-Americans. Cancer Prev Res. 2008; 1(4): 255-65.
42. Spitz MR, Amos CI, Land S, Wu X, Dong Q, Wenzlaff AS, et al. Role of selected genetic variants in lung cancer risk in African Americans. J Thorac Oncol. 2013; 8(4): 391-7. doi: 10.1097/JTO.0b013e318283da29 PMID: 23454887
43. Pinsky PF. Racial and ethnic differences in lung cancer incidence: How much is explained by differences in smoking patterns? (United States). Cancer Causes Control. 2006; 17(8): 1017-24. PMID: 16933052